Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Mar;76(3):740-742.
doi: 10.1016/j.jhep.2021.11.014. Epub 2021 Nov 20.

Assessing causal relationships between COVID-19 and non-alcoholic fatty liver disease

Dong Liu  1 , Qianlong Zhang  1 , Pinqing Bai  2 , Jian Zhao  3
Affiliations
Comment

Assessing causal relationships between COVID-19 and non-alcoholic fatty liver disease

Dong Liu et al. J Hepatol. 2022 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare no conflicts of interest that relate to this work. Please refer to the accompanying ICMJE disclosure forms for further details.

Figures

Fig. 1
Fig. 1
The genome-wide significant variants and bidirectional MR results of COVID-19 infection, hospitalized COVID-19, severe COVID-19 cases, and NAFLD. (A) The genome-wide significant variants associated with COVID-19 infection, hospitalized COVID-19, severe COVID-19 cases, and NAFLD. (B) MR analysis results of COVID-19 on NAFLD. (C) MR analysis results of NAFLD on COVID-19. (D) Forest plot of MR results of COVID-19 on NAFLD. (E) Forest plot of MR results of NAFLD on COVID-19. ∗COVID-19, coronavirus disease 2019; EA, effect allele; EAF, effect allele frequency; MR, Mendelian randomization; NAFLD, non-alcoholic fatty liver disease; OA, other allele. (This figure appears in color on the web.)
See this image and copyright information in PMC

Comment on

References

    1. Ji D., Qin E., Xu J., Zhang D., Cheng G., Wang Y., et al. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. J Hepatol. 2020;73(2):451–453. - PMC - PubMed
    1. Valenti L., Jamialahmadi O., Romeo S. Lack of genetic evidence that fatty liver disease predisposes to COVID-19. J Hepatol. 2020;73(3):709–711. - PMC - PubMed
    1. Davey Smith G., Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89–R98. - PMC - PubMed
    1. COVID-19 Host Genetics Initiative The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur J Hum Genet. 2020;28(6):715–718. - PMC - PubMed
    1. Hemani G., Zheng J., Elsworth B., Wade K.H., Haberland V., Baird D., et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7 - PMC - PubMed